Press "Enter" to skip to content

New patent for Optinose Us drug XHANCE

0
Copyright © DrugPatentWatch. Originally published at New patent for Optinose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE
Annual Drug Patent Expirations for XHANCE

Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.

XHANCE drug price trends.

Drug patent litigation for XHANCE.

This drug has one hundred and eigthy-four patent family members in twenty-eight countries.

The generic ingredient in XHANCE is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Optinose Us drug XHANCE
    Do NOT follow this link or you will be banned from the site!